English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Hematological cancer patients suffer from long-term physical and psychological comorbidities associated with treatment and disease course, including anxiety, depression, fatigue, and reduced quality of life. Meditative movement (i.e., yoga, qigong tai chi) is a form of complementary and integrative medicine that has received growing interest in recent decades. Meditative movement is efficacious for improving a variety of outcomes in other cancers, including mood, fatigue and quality of life. There is much less research examining the effects of meditative movement on hematological cancer patients. The purpose of this study was to systematically review the literature related to the effects of meditative movement specifically in hematological cancers. The findings of this review will help in making recommendations for future research. Methods: Search strategies were developed by a medical librarian to scan the literature for published studies examining the effects of meditative movement (i.e., yoga, tai chi, or qigong) on hematological cancer patients. Results: Four studies met our eligibility criteria. Conclusions: There is preliminary evidence to support the effects of meditative movement on fatigue and sleep quality among hematological cancer patients, but particularly regarding yoga and qigong. No research has been done investigating tai chi on hematological cancer patients. We suggest the need for future research to continue to examine the effects of meditative movement on hematological cancer patients and to determine the minimal dose at which the effects of meditative movement begin to occur. *Correspondence to: Ryan Eckert, Mays Cancer Center, UT Health San Antonio, 7979 Wurzbach Road, San Antonio, TX 78229, USA, Tel: 781-588-0237; E-mail: eckertr@uthscsa.edu

The use of meditative movement as a non-pharmacologic approach in hematological cancer patients: A systematic review of the literature